Offers Claimed: 145
Downloaded Today: 134
USARx offers the following ways to purchase this medication. Choose the Best option for you!
Yes100% of Medicare Part D and Medicare Advantage plans cover this drug.
It depends. Which coverage stage are you in? Click on a tab below…
$5 – $183
In the Deductible co-pay stage, you are responsible for the full cost of your prescriptions. Your Medicare deductible cannot exceed $360 in 2016.
Here are some ways that may lower the cost of your ezetimibe prescription.
If your Medicare co-pay is higher, you can save money by using a USARx coupon instead.
Applies to ezetimibe: oral tablet
Along with its needed effects, ezetimibe may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Frequency not determined
Some side effects of ezetimibe may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
For Healthcare Professionals
Applies to ezetimibe: oral tabletGeneral
The most frequently reported side effects were upper respiratory tract infection, diarrhea, arthralgia, sinusitis, and pain in extremity.Gastrointestinal
Common (1% to 10%): Abdominal pain, diarrhea, flatulence
Uncommon (0.1% to 1%): Dyspepsia, gastroesophageal reflux disease, nausea
Postmarketing reports: Pancreatitis, constipationImmunologic
Postmarketing reports: AnaphylaxisMusculoskeletal
Common (1% to 10%): Arthralgia, pain in extremity
Uncommon (0.1% to 1%): Muscle spasms, neck pain
Postmarketing reports: Myalgia, myopathy, rhabdomyolysisRespiratory
Common (1% to 10%): Upper respiratory tract infection, sinusitis
Uncommon (0.1% to 1%): Cough
Postmarketing reports: DyspneaHypersensitivity
Postmarketing reports: Hypersensitivity reactionHepatic
Uncommon (0.1% to 1%): Gamma-glutamyltransferase increased, liver function test abnormal, AST/ALT increased
Postmarketing reports: Hepatitis, liver transaminases increased, cholelithiasis, cholecystitisHematologic
Postmarketing reports: ThrombocytopeniaNervous system
Uncommon (0.1% to 1%): Dizziness
Postmarketing reports: Paresthesia, headachePsychiatric
Postmarketing reports: DepressionCardiovascular
Uncommon (0.1% to 1%): Hot flush, hypertensionDermatologic
Postmarketing reports: Angioedema, rash, urticaria, erythema multiformeMetabolic
Uncommon (0.1% to 1%): Appetite decreasedOther
Common (1% to 10%): Fatigue, influenza
Uncommon (0.1% to 1%): Chest pain, pain, creatine phosphokinase increased
Postmarketing reports: Asthenia
May 9, 2021
March 31, 2021
March 29, 2021
March 27, 2021
January 25, 2021
February 23, 2021